China
artificial organs market is expected to witness impressive growth rate during
forecast period, 2024-2028. The increasing pool of patients waiting for organ transplants
along with rise in acceptance of organ transplants are expected to bolster the
growth of the market. Also, the growing occurrences of chronic diseases, such
as cardiovascular diseases, chronic kidney diseases, and others are propelling
the growth of the market. In 2021, China has over 10 million patients
suffering from heart failure, with many requiring heart transplant surgeries.
Also, increasing geriatric population which is highly prone to organ failure is
propelling the demand for artificial organs, which, in turn, is strengthening
the growth of the market. According to the report of Seventh National Census
in China, in 2020, the proportion of people aged 65 and over in the total
population were 13.5%. The frequent incidences of road accidents and
injuries leads to amputations are also increasing the demand for artificial
organs. Additionally, increasing awareness about artificial organs among
population is also contributing for the market’s growth.
Technological
Advancements
Rise
in adoption of advanced tools and techniques in the medical as well as
healthcare sector are expected to bolster the growth of the China artificial
organs market in the upcoming years. The advent of latest technologies such as
the development of new artificial organs based on electro physical and optical
technologies, 3D printing of biomaterials, among others are projected to
facilitate the growth of artificial organs market in the country. In 2021,
CH Biomedical in Suzhou, and East China's Jiangsu Province, developed first
domestic magnetically levitated artificial heart. The device uses the same
principle which is used to run high-speed maglev trains. This artificial heart
increases the pumping power of the patient's failing heart, allowing it to
deliver oxygen-rich blood throughout the body.
Increasing
Occurrences of Organ Failures
Increase
in number of cases suffering from organ failure in the country are projected to
strengthen the growth of the market. According to a study, around 1 to 1.5
million people in China requires organ transplant every year. This is
attributed to the increasing incidences of chronic diseases. Chronic diseases
are often caused due to the changing lifestyle, and rising consumption of
unhealthy foods, alcohol, among others, thereby, impelling the growth of the
market. For instance, the major cause for kidney failure is diabetes and
hypertension, due to which, there is an increase in demand for kidney
transplantation. In 2019, around 47,382 Chinese patients were waiting for
kidney transplantation.
Download Free Sample Report
Market Segmentation
China artificial organs
market is segmented into organ type, technology, material type, company and
region. Based on organ type, the market is categorized into artificial heart,
artificial kidney, artificial pancreas, and others. Based on technology, the
market is bifurcated into electronic bionics, and mechanical. Based on material
type, the market is segmented into silicon, plastic, and steel. In terms of
region, the market is segmented into South-Central China, South-West China,
East China, North-East China, North-West China, and North China.
Market Players
Chengdu Baishixing Science
& Technology Industry Co Ltd, Regenovo Biotechnology, Abiomed Inc., Cyfuse
Biomedical, Nipro Corporation, Medtronic Inc, Boston Scientific Corporation,
Terumo Corporation, Tibion Corporation and Baxter International Inc, are some
of the leading companies operating in the market.
|
Attribute
|
Details
|
|
Base Year
|
2022
|
|
Historic Data
|
2018 – 2021
|
|
Estimated Year
|
2023
|
|
Forecast Period
|
2024 – 2028
|
|
Quantitative Units
|
Revenue in USD Million and CAGR for
2018-2022 and 2023E-2028F
|
|
Report coverage
|
Revenue forecast, company share, competitive landscape, growth
factors, and trends
|
|
Segments covered
|
·
Organ Type
·
Technology
·
Material Type
|
|
Regional scope
|
South-Central China, South-West China, East China, North-East
China, North-West China, North China
|
|
Key companies profiled
|
Chengdu Baishixing Science &
Technology Industry Co Ltd, Regenovo Biotechnology, Abiomed Inc., Cyfuse
Biomedical, Nipro Corporation, Medtronic Inc, Boston Scientific Corporation,
Terumo Corporation, Tibion Corporation and Baxter International Inc
|
|
Customization scope
|
10% free report customization with purchase. Addition or
alteration to country, regional & segment scope.
|
|
Pricing and purchase options
|
Avail customized purchase options to meet
your exact research needs. Explore purchase options
|
|
Delivery Format
|
PDF and Excel through Email
(We can also provide the editable version of the report in PPT/Word format on
special request)
|
Report Scope:
In this report, China artificial
organs market has been segmented into following categories, in addition to the
industry trends which have also been detailed below:
- China Artificial Organs Market, By Organ Type:
- Artificial
Heart
- Artificial
Kidney
- Artificial
Pancreas
- Others
- China Artificial Organs Market, By
Technology:
- Electronic
Bionics
- Mechanical
·
China Artificial Organs Market, By Material Type:
o Silicon
o Plastic
o Steel
- China Artificial Organs Market, By Region:
o South-Central China
o South-West China
o East China
o North-East China
o North-West China
o North China
Competitive Landscape
Company Profiles: Detailed analysis of the
major companies present China artificial organs market
Available Customizations:
With the given market data, TechSci
Research offers customizations according to a company’s specific needs. The
following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market
players (up to five).
China artificial organs market is an upcoming report to be released
soon. If you wish an early delivery of this report or want to confirm the date
of release, please contact us at [email protected]